University of North Carolina at Chapel Hill, Chapel Hill, NC
Brigham Young University at Provo, Provo, UT
Bradley Layton, PhD, is a Senior Research Epidemiologist at RTI Health Solutions. He has considerable experience in the design, conduct, analysis, and reporting of epidemiologic studies and has over 10 years of experience in the field of pharmacoepidemiology. His experience and publications span a wide range of substantive areas, including renal, cardiovascular, men’s health, vaccines, and pregnancy, and incorporate multidatabase and multinational studies. Dr. Layton also has experience with epidemiologic methods, lecturing to clinical and public health audiences about observational study design, large database utilization, and propensity score analysis. Dr. Layton received his master's and doctorate degrees in epidemiology from the Department of Epidemiology in the Gillings School of Global Public Health, University of North Carolina at Chapel Hill, focusing in pharmacoepidemiology with an emphasis in renal disease. Prior to joining RTI-HS, he was a member of the faculty in the Pharmacoepidemiology Program in the University of North Carolina Department of Epidemiology, where he accrued vast experience leading studies that utilized secondary health care data sets to evaluate pharmaceutical use, safety, and effectiveness, and he is currently an adjunct associate professor at the University of North Carolina. As a faculty member, he organized and taught in several workshops and training courses for epidemiologists in pharmaceutical companies, as well as a set of methods workshops for epidemiologists at the Food and Drug Administration. Dr. Layton also is an active member of the International Society of Pharmacoepidemiology, having served on the Scientific Program Committee as the chair of the spotlight poster sessions, on the Public Policy Committee, and as the Vice-chair of the Vaccine Special Interest Group.